| Literature DB >> 24338767 |
Maryam Mardani1, Azadeh Andisheh-Tadbir, Bijan Khademi, Mohammad Javad Fattahi, Shapour Shafiee, Maryam Asad-Zadeh.
Abstract
Osteopontin (OPN) is a multifunctional glycophosphoprotein that was detected in many carcinomas, and it may have a prognostic role. The aim of this study was to determine osteopontin serum levels in patients with oral squamous cell carcinoma (OSCC) and investigated its correlation with clinicopathological features of tumor. Using an ELISA kit, we assessed and compared the circulating levels of OPN in blood serum of 45 oral squamous cell carcinoma patients with 45 healthy control samples. The serum osteopontin level in patients with OSCC was significantly higher (145.8 ± 14.6 ng/ml, n = 45) compared with the healthy controls (53.9 ± 9.6 ng/ml, n = 45, p < 0.001). Mean serum osteopontin level was significantly higher in patients with nodal metastasis (p = 0.03) and higher stage (p = 0.02). Findings of the present study suggest that OPN may have a potential role in pathogenesis of OSCC and it may be used as a tool for monitoring tumor progression.Entities:
Mesh：
Substances：
Year: 2013 PMID： 24338767 DOI： 10.1007/s13277-013-1506-4
Source DB: PubMed Journal: Tumour Biol ISSN： 1010-4283